Covetrus, inc. (CVET)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18
ASSETS
Current assets:
Cash and cash equivalents

205

130

68

55

73

23

Accounts receivable, net of allowance of $8 and $8

525

426

466

458

461

431

Inventories, net

572

636

598

556

594

564

Other receivables

70

67

77

61

59

49

Prepaid expenses and other

40

30

35

42

32

19

Assets held for sale (Note 3)

48

51

-

-

-

0

Total current assets

1,460

1,340

1,244

1,172

1,219

1,086

Non-current assets:
Property and equipment, net of accumulated depreciation of $89 and $84

94

93

104

100

94

69

Operating lease right-of-use assets, net (Note 5)

123

84

75

60

62

-

Goodwill

1,154

1,154

1,156

2,102

2,105

750

Other intangibles, net (Note 6)

605

643

679

717

728

208

Investments and other

51

47

70

39

61

120

Total assets

3,487

3,361

3,328

4,190

4,269

2,233

LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable

466

520

483

425

431

440

Current maturities of long-term debt and other borrowings (Note 8)

61

62

47

32

36

1

Accrued payroll and related liabilities

45

44

51

41

40

37

Accrued taxes

28

18

26

38

19

17

Other current liabilities

180

164

144

138

144

77

Liabilities held for sale (Note 3)

20

21

-

-

-

0

Total current liabilities

800

829

751

674

670

572

Non-current liabilities:
Long-term debt and other borrowings, net (Note 8)

1,298

1,125

1,141

1,154

1,167

24

Deferred taxes

46

47

11

28

51

16

Other liabilities

132

94

86

74

70

35

Total liabilities

2,276

2,095

1,989

1,930

1,958

647

Redeemable non-controlling interests (Note 11)

9

10

10

13

17

92

Shareholders' equity:
Common stock, $0.01 par value per share, 675,000,000 shares authorized; 111,854,439 shares issued and outstanding as of March 31, 2020; 111,620,507 shares issued and outstanding as of December 31, 2019

1

1

1

1

1

0

Net former parent investment

-

-

0

0

0

1,576

Accumulated other comprehensive loss (Note 12)

-116

-86

-102

-78

-82

-82

Additional paid-in capital

2,390

2,381

2,369

2,357

2,396

0

Accumulated deficit

-1,073

-1,040

-939

-33

-21

0

Total shareholders’ equity

1,202

1,256

1,329

2,247

2,294

1,494

Total liabilities, redeemable non-controlling interests, and shareholders’ equity

3,487

3,361

3,328

4,190

4,269

2,233